thebench.bio #1 Ecosystem for the Bio-Tech Industry

Software Daily Summary

Software Daily Summary: What Happened on November 13, 2026

Latch Bio benchmark finds AI agents pass fewer than one-third of virus questions

A Microsoft outage disrupted the UK medicines regulator’s email, while nf-core changed how it reviews new pipeline proposals.

  • Updated
  • Read from 4 articles, 4 publications
  • L N

Today in brief

In Latch Bio’s respiratory-virus benchmark, the top AI configuration passed 30.2% of attempts. Every other configuration scored below 20%.1 The UK medicines regulator said a global Microsoft outage disrupted its email, while its phone lines and public safety work continued.2

Also worth knowing

  • L

    Latch Bio tested 18 models in 22 configurations on 64 questions, with three attempts per question. Questions about antiviral activity and resistance had the lowest average pass rate, at 7%.1

  • N

    nf-core moved proposal guidance ahead of repository-creation instructions, urging developers to discuss scope and licensing and propose pipelines before coding.3

  • The UK medicines regulator directed people with urgent questions to call 020 3080 6000 during the Microsoft outage.2

  • A video recap of AMP 2026 covered AI and DNA methylation in brain tumor classification, multi-omic liquid biopsy profiling, and whether clinicians using AI perform better than AI alone.4

Also published